CDC and NIH collaborate to create Sudden Death in Young Registry

NewsGuard 100/100 Score

A registry of deaths in young people from conditions such as heart disease and epilepsy is being created to help researchers define the scope of the problem and set future research priorities. The National Institutes of Health and the Centers for Disease Control and Prevention are collaborating to create the Sudden Death in the Young Registry.

"The sudden death of a child is tragic and the impact on families and society is incalculable," said Jonathan Kaltman, M.D., chief of the Heart Development and Structural Diseases Branch within the Division of Cardiovascular Sciences at the NIH's National Heart, Lung, and Blood Institute (NHLBI). "This registry will collect comprehensive, population-based information on sudden unexpected death in youths up to age 24 in the United States. It is a critical first step toward figuring out how to best prevent these tragedies."

Cases of sudden cardiac death or sudden unexpected death in epilepsy (SUDEP) are not routinely or systematically reported, and no commonly agreed upon standards or definitions for reporting currently exist. Complete information has not been collected on the incidences, causes, and risk factors for sudden death in the young. The lack of evidence fuels disagreements about the best prevention approach. Sudden cardiac death, also called sudden cardiac arrest, happens when the heart suddenly and unexpectedly stops beating and blood stops flowing to the brain and other vital organs.

Researchers know that the risk for sudden death in the young increases if the person has a heart-related condition. Examples include hypertrophic cardiomyopathy (thick heart muscle), congenital abnormalities or disorders of the coronary arteries that supply the heart with blood, arrhythmogenic right ventricular cardiomyopathy (a heart muscle problem), long QT syndrome (a disorder of the heart's electrical activity), or other heart abnormalities. Additionally, individuals who have epilepsy may die suddenly and unexpectedly, without a structural or drug-related cause of death found at autopsy. Little is known about how often SUDEP occurs or about factors that put any individual with epilepsy at risk.

The registry will estimate the incidence of sudden death in infants, children, and young adults by collecting comprehensive data on each recorded case. The registry is an expansion of the CDC's Sudden Unexpected Infant Death Case Registry, which currently tracks sudden unexpected deaths in children up to age 1 in nine states.

State public health agencies will be able to apply to the CDC to participate in the registry in 2014. The registry will track all sudden unexpected deaths in youths up to age 24 in as many as 15 states or major metropolitan areas. Child death review teams from each state will examine findings from death scene investigations and will review and compile information from medical records, autopsy reports, and other pertinent data sources for each case. A panel of medical experts, medical examiners, and forensic pathologists will help to develop and guide the implementation of standardized autopsy protocols and case definitions.

Data will be entered into a centralized database managed by a data coordinating center at the Michigan Public Health Institute. After obtaining parental consent, blood samples from a subset of cases will be sent to a centralized biorepository. The data will not contain personally identifiable information. The resulting registry will become a resource for scientists to learn more about the causes of sudden death in the young and ultimately to develop better diagnostic and prevention approaches.

The NIH's NHLBI will analyze data related to sudden cardiac death while the National Institute for Neurological Disorders and Stroke (NINDS) will participate in the registry by reviewing data on SUDEP.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy